Search - tctmd.com

Displaying 501 - 520 of 1277

Sort: Relevancy | Date

Presentation TCT 2014

Next Steps: Translational Opportunities and Methodologies to Get Us Back on Track!

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn

September 13, 2014

Presentation TCT 2014

Does One Size Fit All for Renal Denervation to Work? From Symplicity to Complexity

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Felix Mahfoud

September 13, 2014

Presentation TCT 2014

TCT 403: Peripheral Endothelial Function and Sympathetic Influence on Dermal Microcirculation Correlate with Long-term Blood Pressure Response in Renal Denervation Patients

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Ulrich Hink

September 13, 2014

Presentation TCT 2014

Preclinical Insights Into the Optimal Ablation Location for Renal Denervation Procedures

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Robert J. Melder

September 13, 2014

Presentation TCT 2014

TCT 402: Renal Norepinephrine Reduction Following Radiofrequency Renal Denervation Correlates with Extent of Nerve Ablation: Roles of Ablation Areas, Anatomy, and Number of Treatments

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Rami Tzafriri

September 13, 2014

Presentation TCT 2014

There Is Hope for Producing Preclinical Models for Successful Device Development

Presenter: Gregory J. Wilson

September 13, 2014

Presentation TCT 2014

Lack of Preclinical Understanding Underlies the Negative Randomized Trial Results!

Presenter: Robert S. Schwartz

September 13, 2014

Presentation TCT 2014

Renal Nerve Microanatomy - The Foundation for RDN Technologies

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Michael Joner

September 13, 2014

Presentation TCT 2014

Affirmative: Time to Move On!

Presenter: Sanjay Kaul, Ajay J. Kirtane, Sripal Bangalore

September 13, 2014

Presentation TCT 2014

Negatory: There are Logical Reasons for Why Renal Artery Denervation Failed in SIMPLICITY HTN-3!

Presenter: Sanjay Kaul, Ajay J. Kirtane, David E. Kandzari

September 13, 2014

$SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups$

Presentation TCT 2014

SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups

Presenter: Patrick W. Serruys, Deepak L. Bhatt

September 13, 2014

News Daily News

Worse LV Function After Primary PCI in Women May Be Due to Delay in Presentation

L.A. McKeown

September 13, 2014

News Industry News

Twelve-Month Data from St. Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for Patients

September 13, 2014

News Conference News TCT 2014

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

September 13, 2014

News Conference News TCT 2014

Experts Debate Future of Renal Denervation Therapy

September 13, 2014

News Daily News

El Empeoramiento de la Función VI tras una PCI Primaria de las Mujeres podría Deberse a Retrasos a la Hora de Acudir al Hospital

L.A. McKeown

September 13, 2014

News Daily News

一项观察性研究证实CABG后的肾损伤风险高于PCI

Todd Neale

September 11, 2014

News Daily News

Un Estudio Observacional Afirma que la Lesión Renal Aguda es Más Alta Post CABG que Post PCI

Todd Neale

September 11, 2014

News Daily News

Observational Study Affirms Higher Kidney Injury Risk After CABG vs PCI

Todd Neale

September 11, 2014

News Industry News

Medtronic NC Euphora(TM) Coronary Balloon Receives FDA Clearance

September 11, 2014

Advertisement

Next Steps: Translational Opportunities and Methodologies to Get Us Back on Track!

Does One Size Fit All for Renal Denervation to Work? From Symplicity to Complexity

TCT 403: Peripheral Endothelial Function and Sympathetic Influence on Dermal Microcirculation Correlate with Long-term Blood Pressure Response in Renal Denervation Patients

Preclinical Insights Into the Optimal Ablation Location for Renal Denervation Procedures

TCT 402: Renal Norepinephrine Reduction Following Radiofrequency Renal Denervation Correlates with Extent of Nerve Ablation: Roles of Ablation Areas, Anatomy, and Number of Treatments

There Is Hope for Producing Preclinical Models for Successful Device Development

Lack of Preclinical Understanding Underlies the Negative Randomized Trial Results!

Renal Nerve Microanatomy - The Foundation for RDN Technologies

Affirmative: Time to Move On!

Negatory: There are Logical Reasons for Why Renal Artery Denervation Failed in SIMPLICITY HTN-3!

SYMPLICITY HTN-3: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Refractory Hypertension: 12-Month Results in Subgroups

Worse LV Function After Primary PCI in Women May Be Due to Delay in Presentation

Twelve-Month Data from St. Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for Patients

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

Experts Debate Future of Renal Denervation Therapy

El Empeoramiento de la Función VI tras una PCI Primaria de las Mujeres podría Deberse a Retrasos a la Hora de Acudir al Hospital

一项观察性研究证实CABG后的肾损伤风险高于PCI

Un Estudio Observacional Afirma que la Lesión Renal Aguda es Más Alta Post CABG que Post PCI

Observational Study Affirms Higher Kidney Injury Risk After CABG vs PCI

Medtronic NC Euphora(TM) Coronary Balloon Receives FDA Clearance

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content